• Darling Ingredients’ Rousselot unit secured U.S. Patent No. US12636339 for Nextida GC, a collagen peptide positioned to support post-meal blood glucose regulation.
• The patent covers the production process and use of Nextida GC as a dietary supplement ingredient, targeting demand for non-pharmaceutical metabolic health options.
• Patents for Nextida GC were also granted in Australia, Europe, Japan, China, with additional applications pending in other markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Darling Ingredients Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606031710BIZWIRE_USPR_____20260602_BW818463) on June 03, 2026, and is solely responsible for the information contained therein.